Login
Communauté Vinci
Extérieur
Si votre nom d'utilisateur ne se termine pas par @vinci.be ou @student.vinci.be, utilisez le formulaire ci-dessous pour accéder à votre compte de lecteur.
Titre : | Perineural Dextrose and Corticosteroid Injections for Ulnar Neuropathy at the Elbow: A Randomized Double-blind Trial (2020) |
Auteurs : | Liang-Cheng Chen ; Tsung-Yen Ho ; Yu-Ping Shen ; Yu-Chi Su ; Tsung-Ying Li ; Chia-Kuang Tsai ; Yung-Tsan Wu |
Type de document : | Article |
Dans : | Archives of Physical Medicine and Rehabilitation (Vol. 101, n° 8, 2020) |
Article en page(s) : | p. 1296-1303 |
Note générale : | https://doi.org/10.1016/j.apmr.2020.03.016 |
Langues: | Anglais |
Descripteurs : |
HE Vinci Glucose ; Neuropathies ulnaires ; Réadaptation |
Résumé : |
Objective
To assess the effects of perineural corticosteroid and 5% dextrose water (D5W) injections in patients with mild to moderate ulnar neuropathy at the elbow (UNE). Design Prospective, randomized, double-blind, controlled trial (6-month follow-up). Setting Outpatients of local medical center settings. Participants Patients (N=36) with mild to moderate UNE were randomized, and 33 participants were included in the final data analysis. Interventions Patients were administered a single perineural injection with 5 mL D5W and 3 mL corticosteroid (triamcinolone acetonide, 10mg/mL) mixed with 2 mL normal saline under ultrasound guidance in the dextrose and steroid groups, respectively. Main Outcome Measures The visual analog scale digital pain or paresthesia/dysesthesia score was the primary outcome. The secondary outcomes were the Disabilities of the Arm, Shoulder, and Hand questionnaire, motor nerve conduction velocity, and cross-sectional area (CSA) of the ulnar nerve. The measurement assessment was conducted before and 1, 3, 4, and 6 months after injection. Results Thirty-three patients completed the study. Both injections were found to be equally effective at most measurement points, although the dextrose group experienced larger reductions in symptom severity and CSA of the ulnar nerve from the third month onward. Conclusions We suggest D5W as a more suitable injectate for perineural injection in patients with UNE. |
Disponible en ligne : | Oui |
En ligne : | https://login.ezproxy.vinci.be/login?url=https://www.sciencedirect.com/science/article/pii/S000399932030215X |